Biolargo Inc (BLGO)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.2827 -0.0023 (-0.81%) 03/20/25 [OTC US]
N/A x N/A N/A x N/A
Post-market 0.2827 unch (unch) 15:54 ET
for Thu, Mar 20th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
Sales | 12,230 | 5,884 | 2,531 | 2,432 | 1,861 |
Cost of Goods | 6,076 | 3,027 | 1,428 | 1,204 | 945 |
Gross Profit | 6,154 | 2,857 | 1,103 | 1,228 | 916 |
Operating Expenses | 10,810 | 8,274 | 8,309 | 9,015 | 8,557 |
Operating Income | -4,580 | -5,390 | -6,778 | -7,583 | -6,696 |
Interest Expense | 91 | 53 | 234 | 1,923 | 3,996 |
Other Income | 23 | 311 | 118 | -194 | -748 |
Pre-tax Income | -4,648 | -5,132 | -6,894 | -9,700 | -11,440 |
Net Income Continuous | -4,648 | -5,132 | -6,894 | -9,700 | -11,440 |
Minority Interests | -1,144 | -659 | 186 | -1,268 | -750 |
Net Income | $-3,504 | $-4,473 | $-7,080 | $-8,432 | $-10,690 |
EPS Basic Total Ops | -0.02 | -0.02 | -0.03 | -0.05 | -0.08 |
EPS Basic Continuous Ops | -0.02 | -0.02 | -0.03 | -0.05 | -0.08 |
EPS Diluted Total Ops | -0.02 | -0.02 | -0.03 | -0.05 | -0.08 |
EPS Diluted Continuous Ops | -0.02 | -0.02 | -0.03 | -0.05 | -0.08 |
EPS Diluted Before Non-Recurring Items | -0.02 | N/A | -0.03 | -0.05 | -0.07 |
EBITDA(a) | $-4,308 | $-5,345 | $-6,758 | $-7,525 | $-6,631 |